Log in to save to my catalogue

Oblique Therapeutics announces achievement of key milestone in its aKRAS-mAb program and Abiprot pla...

Oblique Therapeutics announces achievement of key milestone in its aKRAS-mAb program and Abiprot pla...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_incontextgauss_IBG_A676883111

Oblique Therapeutics announces achievement of key milestone in its aKRAS-mAb program and Abiprot platform

About this item

Full title

Oblique Therapeutics announces achievement of key milestone in its aKRAS-mAb program and Abiprot platform

Publisher

PR Newswire Association LLC

Journal title

PR newswire, 2021-09-28

Language

English

Publication information

Publisher

PR Newswire Association LLC

More information

Alternative Titles

Full title

Oblique Therapeutics announces achievement of key milestone in its aKRAS-mAb program and Abiprot platform

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_incontextgauss_IBG_A676883111

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_incontextgauss_IBG_A676883111

How to access this item